Weight Watchers International, Inc. (WW) Tops Q4 EPS by 4c, Revenues Beat; Offers FY20 EPS/Revenues Guidance Above Consensus

Go back to Weight Watchers International, Inc. (WW) Tops Q4 EPS by 4c, Revenues Beat; Offers FY20 EPS/Revenues Guidance Above Consensus

Weight Watchers International (WW) PT Raised to 'Street High' $63 at DA Davidson

February 26, 2020 8:17 AM EST

DA Davidson analyst Linda Bolton Weiser raised the price target on Weight Watchers International (NASDAQ: WW) to a 'Street High' $63.00 (from $56.00) while maintaining a Buy rating.

The analyst commented, "WW reported a successful diet season, and guided to Y/Y subscriber growth... More

Weight Watchers International (WW) PT Raised to $56 at DA Davidson on Positive App Download Trends

February 24, 2020 6:22 AM EST

DA Davidson analyst Linda Bolton Weiser raised the price target on Weight Watchers International (NASDAQ: WW) to $56.00 (from $33.00) on the belief that the consensus 5% sales growth in 2020 is modest and subscriber growth of at least 10% is possible.

The analyst reiterated a Buy rating,... More

Pre-Open Stock Movers 02/21: (BXRX) (CRC) (DBX) Higher (TRUE) (BXC) (EYPT) Lower (more...)

February 21, 2020 9:12 AM EST

Pre-Open Stock Movers

Baudax Bio, Inc. (NASDAQ: BXRX) 31.7% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ANJESO (meloxicam injection), which is indicated for the management of moderate to... More

DA Davidson Upgrades Weight Watchers International (WW) to Buy; Sees Faster-than-Expected Growth

February 21, 2020 6:37 AM EST

(Updated - February 21, 2020 8:32 AM EST)

(updated to add analyst comments)

DA Davidson analyst Linda Bolton Weiser upgraded Weight Watchers International (NASDAQ: WW) from Neutral to Buy and raises its price target to $56 (from $33), citing proprietary data showing faster than expected growth.

The... More